After the match ended, followed by much drama, he sat down for the press conference and responded to questions, a few of them ...

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most ...

Multinational pharmaceutical firms are pulling pack or pausing investments in the UK, blaming a lack of competitive drug ...

The year 2023 marked the debut of groundbreaking innovations to prevent severe RSV infections in infants. Now protected ...

The withdrawal of a series of high-profile investments over the past few days has sent the strongest signal to the government ...

Its decision comes as the industry says there is a lack of government investment and as the US pressures firms to invest ...

South SF lab uses AI to strip hallucinations from psychedelics while keeping therapeutic benefits. Silicon Valley ...

FDA recommends that IO Biotech not submit a Biologics License Application (BLA) based on the data from the IOB-013 clinical trial Company plans to design new registrational study for Cylembio for the ...

While pregnant with her third child last year, Alison Carroll pondered options that hadn’t been available during her first ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout ...

A letter to the Competition and Markets Authority from three NGOs accuses companies of “suspected” anticompetitive behavior.

In an American team stacked with talent from the top college’s in the country, it was finance executive Stewart Hagestad, who ...